• Our Offering
    • Biologics
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • Drug Product
      • mRNA / LNP
      • Expression Technologies
    • Small Molecules
      • Drug Substance (API)
      • Particle Engineering
      • Drug Product
    • Cell & Gene
      • Process Development
      • cGMP manufacturing
      • Allogeneic
      • Autologous
      • Viral Vectors
      • Bioscience Products
    • Capsules & Health Ingredients
      • Health Ingredients
      • Nutraceutical capsules
      • Pharmaceutical capsules
      • Capsule filling equipment
  • Our Company
    • About Us
      • Purpose and Strategy
      • Leadership
      • History
      • Locations
      • Partnering with Us
      • Events
    • News and Media
      • News Archive
      • Media Library
      • Logo Guidelines
      • Blog
      • Podcast
      • Media Inquiries
    • Investor Relations
      • Shareholder Information
      • Agenda and Events
      • Financial Reporting
      • Annual Report
      • Corporate Governance
      • Ethics and Compliance
      • Investor Inquiries
    • Sustainability
      • Performance
      • People
      • Planet
      • Community
      • Global Quality
      • Responsible Sourcing
  • Careers
    • Overview
    • Life at Lonza
      • What We Offer
      • Career Stories
    • Job Search
      • Join Our Talent Community
      • Recruitment Process
      • Students, Graduates and Apprentices
  • Contact
  • Trending Topics
    Annual Report 2022
    Lonza Launches Share Buyback Program of up to CHF 2 Billion
    Podcast Episode 4: View On Injectable Delivery Devices
    New Cambridge, USA Lab Expands Our Early De-risking Capacity
    Expanded CGT Process Development Laboratories in the US & EU
    PBPK Modeling Service to De-risk Drug Development
Trending Topics
Annual Report 2022
Lonza Launches Share Buyback Program of up to CHF 2 Billion
Podcast Episode 4: View On Injectable Delivery Devices
New Cambridge, USA Lab Expands Our Early De-risking Capacity
Expanded CGT Process Development Laboratories in the US & EU
PBPK Modeling Service to De-risk Drug Development
Our Offering
Corporate
Biologics
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • Drug Product
  • mRNA / LNP
  • Expression Technologies
Small Molecules
  • Drug Substance (API)
  • Particle Engineering
  • Drug Product
Cell & Gene
  • Process Development
  • cGMP manufacturing
  • Allogeneic
  • Autologous
  • Viral Vectors
  • Bioscience Products
Capsules & Health Ingredients
  • Health Ingredients
  • Nutraceutical capsules
  • Pharmaceutical capsules
  • Capsule filling equipment
Back
Our Company
Corporate
About Us
  • Purpose and Strategy
  • Leadership
  • History
  • Locations
  • Partnering with Us
  • Events
News and Media
  • News Archive
  • Media Library
  • Logo Guidelines
  • Blog
  • Podcast
  • Media Inquiries
Investor Relations
  • Shareholder Information
  • Agenda and Events
  • Financial Reporting
  • Annual Report
  • Corporate Governance
  • Ethics and Compliance
  • Investor Inquiries
Sustainability
  • Performance
  • People
  • Planet
  • Community
  • Global Quality
  • Responsible Sourcing
Back
Careers
Corporate
Overview
Life at Lonza
  • What We Offer
  • Career Stories
Job Search
  • Join Our Talent Community
  • Recruitment Process
  • Students, Graduates and Apprentices
Back
Contact
Corporate
Back

Original poster gallery

Archived Lonza promotional poster
Archived Lonza promotional poster
Archived Lonza promotional poster
Archived Lonza promotional poster
Archived Lonza promotional poster
Ways to Contact
  • Contact Us
  • Regulatory Support
  • Locations
  • Partnering with Us
Resources
  • Knowledge Center
  • Meet the Experts
  • Upcoming Events
Terms & Conditions
  • Terms and Conditions
  • Legal Disclaimer
  • Privacy Policy
  • California CCPA Notice
  • Transparency in Coverage
Lonza.com
  • Company Overview
  • News & Media
  • Investor Relations
  • Sustainability
  • Careers
  • Sitemap
© 2023 Lonza. All rights reserved.